University of Toronto-ko ikertzaileekin lankidetzan egindako argitalpenak (33)

2024

  1. Early management of adult traumatic spinal cord injury in patients with polytrauma: a consensus and clinical recommendations jointly developed by the World Society of Emergency Surgery (WSES) & the European Association of Neurosurgical Societies (EANS)

    World Journal of Emergency Surgery, Vol. 19, Núm. 1

2023

  1. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)

    Intensive Care Medicine

  2. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    European Respiratory Journal, Vol. 61, Núm. 4

  3. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632

  4. Liver injury in hospitalized patients with COVID-19: An International observational cohort study

    PLoS ONE, Vol. 18, Núm. 9 September

  5. Psychological Health of Surgeons in a Time of COVID-19: A Global Survey

    Annals of Surgery, Vol. 277, Núm. 1, pp. 50-56

2022

  1. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  2. Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study

    Critical Care, Vol. 26, Núm. 1

  3. Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health

    Journal of Mental Health, Vol. 31, Núm. 4, pp. 524-533

2021

  1. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

    Critical Care, Vol. 25, Núm. 1

  2. Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients with Coronavirus Disease 2019: An International Cohort Study

    Critical Care Explorations, Vol. 3, Núm. 11, pp. E0567

  3. Core Outcome Measures for Trials in People with Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery

    Critical Care Medicine, Vol. 49, Núm. 3, pp. 503-516

  4. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?

    Molecular Psychiatry, Vol. 26, Núm. 1, pp. 60-65

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  6. Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

    Urology, Vol. 147, pp. 235-242

  7. Vision, challenges and opportunities for a plant cell atlas

    eLife, Vol. 10

2020

  1. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder

    Nature Communications, Vol. 11, Núm. 1

  2. Core Outcomes Set for Trials in People With Coronavirus Disease 2019

    Critical Care Medicine, Vol. 48, Núm. 11, pp. 1622-1635

  3. Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

    The Journal of urology, Vol. 203, Núm. 6, pp. 1163-1171

  4. International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019

    Critical Care Medicine, Vol. 48, Núm. 11, pp. 1612-1621